Acinar-to-Ductal Metaplasia Induction: A Method to Study Acinar Cell to Ductal Cell Differentiation in 3D Ex Vivo Culture
JoVE Encyclopedia of Experiments
Cancer Research
0 views • 3:21 min • April 30th, 2023
- The exocrine portion of the pancreas constitutes acinar cells and ductal cells. Acinar cells synthesize and secrete digestive enzymes into their lumen. The ductal cells line the tube that delivers these enzymes to the small intestine. To adapt to genetic and environmental stress, acinar cells undergo morphological and functional conversion into duct-like cells, termed acinar-to-ductal metaplasia, or ADM.
At times, ADM may lead to the onset of pancreatic cancer. To induce ADM ex vivo, prepare a chilled collagen cell suspension by combining primary acinar cells with collagen gel kept on ice to prevent matrix solidification. Treat the suspension with a test ADM stimulant or inhibitor of interest.
Distribute the suspension into a culture plate and incubate to facilitate collagen solidification and embed the cells within. Next, pipette an additional volume of media containing the test ADM stimulant or inhibitor of interest over the solidified collagen cell layer.
Incubate the plate for an appropriate duration. With acinar-to-ductal metaplasia induction, pyramidal-shaped primary acinar cells transdifferentiate to form cells with duct cell-like morphology. In the following protocol, we will demonstrate the ex vivo induction of acinar-to-ductal metaplasia in primary murine acinar cells using TGF alpha as a stimulant.
- To make a collagen gel, combine 7 milliliters of type-1 rat tail collagen, 700 microliters of 10 times Waymouth's medium, and 466.6 microliters of 0.34 molar sodium hydroxide in a 50 milliliter tube on ice to make collagen gel. In a 50 milliliter tube, combine equal volumes of cell suspension and collagen gel after three hours' incubation and gently mix. Plate 2,000 microliters one well at a time in a six-well plate while keeping the plate on ice, and swirl to evenly distribute the collagen cell layer.
To solidify the medium, incubate the plate in a cell culture incubator at 37 degrees Celsius and 5% carbon dioxide for 30 minutes. Then add 1.5 milliliters per well of 1 times Waymouth's complete medium with desired stimulus or inhibitors.
Change the medium the following day and then every other day. Depending on the stimulus used, acinar-to-ductal metaplasia, or ADM, can be observed between day three and day five.
Overview
This study focuses on the ex vivo induction of acinar-to-ductal metaplasia (ADM) in primary murine acinar cells. ADM is a process where acinar cells transform into duct-like cells, which can be a precursor to pancreatic cancer. The protocol demonstrates how to induce ADM using TGF alpha as a stimulant.
Key Study Components
Area of Science
- Cell biology
- Pancreatic physiology
- Oncology
Background
- The pancreas has exocrine and endocrine functions.
- Acinar cells secrete digestive enzymes, while ductal cells transport these enzymes.
- Acinar-to-ductal metaplasia can occur under stress conditions.
- Understanding ADM is crucial for insights into pancreatic cancer development.
Purpose of Study
- To provide a detailed protocol for inducing ADM ex vivo.
- To explore the morphological changes in acinar cells during ADM.
- To assess the effects of TGF alpha on acinar cell transformation.
Methods Used
- Preparation of a chilled collagen cell suspension with primary acinar cells.
- Treatment of the suspension with ADM stimulants or inhibitors.
- Embedding cells in solidified collagen for culture.
- Observation of morphological changes over several days.
Main Results
- Acinar cells transdifferentiate into duct-like cells upon ADM induction.
- Changes in cell morphology are observable between days three and five.
- The protocol successfully demonstrates the induction of ADM.
- TGF alpha is effective in stimulating this transformation.
Conclusions
- The study provides a reliable method for inducing ADM in vitro.
- Understanding ADM can help in the study of pancreatic cancer mechanisms.
- This protocol can be utilized for further research on pancreatic diseases.
Frequently Asked Questions
Executive Industry Relevance
Modeling acinar-to-ductal metaplasia (ADM) in 3D ex vivo culture provides a physiologically relevant system to interrogate early pancreatic cancer mechanisms. This approach enables target validation and phenotypic screening by capturing a key transdifferentiation event linked to neoplastic progression. The method supports mechanistic de-risking and predictive confidence in preclinical models of pancreatic ductal adenocarcinoma.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogate therapeutic hypotheses by inducing ADM with TGF alpha or inhibitors to assess pathway involvement in acinar cell transdifferentiation.
- Operational Value: Validate biological targets through quantifiable morphological shifts from pyramidal to duct-like phenotypes in primary murine acinar cells.
- Predictive Value: Support portfolio triage by linking target modulation to ADM suppression or induction as a biomarker of early neoplastic risk.
Screening & Assay Development
- Assay Readiness: Prepare standardized 3D collagen-embedded acinar cell cultures for consistent compound screening against ADM modulators.
- Quantitative Output: Enable time-lapse imaging and morphometric analysis to measure ADM progression between days three and five post-induction.
- Scalability: Support multi-well plate formats for dose-response testing of stimulants or inhibitors in a reproducible ex vivo system.
Translational & Preclinical Research
- Disease Relevance: Model a key early event in pancreatic carcinogenesis to bridge discovery with preclinical validation.
- Translational Continuity: Use induced duct-like phenotypes to evaluate downstream signaling or stromal interactions relevant to tumor microenvironment.
- Risk-Adjusted Decisions: Inform go/no-go criteria based on ADM modulation as a mechanistic readout of cancer-promoting pathways.
Pipeline & Workflow Integration
The ADM induction method fits within the discovery-to-preclinical continuum, enabling hypothesis testing in early drug screening and supporting validation in disease-relevant pancreatic models.
- Discovery Biology: Test how genetic or pharmacological perturbations affect acinar cell plasticity and transdifferentiation capacity.
- Screening: Establish reproducible 3D cultures for evaluating compound effects on ADM induction or inhibition over defined time windows.
- Analytics: Capture morphological and cytoskeletal changes as quantitative endpoints for comparing experimental conditions.
- Translational Research: Link ADM outcomes to pancreatic cancer progression models using primary murine cells as a disease-relevant system.
- Enterprise Reuse: Deploy the collagen-based 3D culture platform across multiple studies targeting pancreatic fibrosis, inflammation, or oncogenic transformation.
Operational & Enterprise Impact
- Scientific Value: Reduce mechanistic ambiguity by modeling a defined cellular transition implicated in pancreatic cancer initiation.
- Operational Value: Standardize ex vivo 3D culture conditions for reproducible ADM induction across laboratories and projects.
- Strategic Value: Improve target selection confidence by validating hits in a pathophysiologically relevant differentiation model.
- Portfolio Impact: Enable risk-based prioritization of compounds that modulate ADM as an early biomarker of neoplastic potential.
Implementation Considerations
- Require expertise in primary cell isolation, 3D extracellular matrix handling, and long-term ex vivo culture maintenance.
- Depend on sterile cell culture incubators, phase-contrast microscopy, and collagen preparation under cold conditions to prevent premature gelation.
- Necessitate standardized operating procedures for cell suspension preparation, collagen mixing, and medium addition to ensure batch consistency.
- Involve adaptation considerations when extending the protocol to human acinar cells or alternative stimulants beyond TGF alpha.
- Include practical limitations such as donor variability in primary acinar cell responsiveness and the finite lifespan of ex vivo cultures.
Biopharma FAQs
Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Related Videos
0 Views
Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells
Related Videos
0 Views
Neuronal Differentiation from Mouse Embryonic Stem Cells In vitro
Related Videos
0 Views
Primary Acinar Cell Isolation: A Method to Isolate Acinar Cells from Mouse Pancreas
Related Videos
0 Views
Isolation and Culture of Mouse Primary Pancreatic Acinar Cells
Related Videos
0 Views
A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies
Related Videos
0 Views
Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
Related Videos
0 Views
Engineering Three-dimensional Epithelial Tissues Embedded within Extracellular Matrix
Related Videos
0 Views
De Novo Generation of Somatic Stem Cells by YAP/TAZ
Related Videos
0 Views
Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture
Related Videos
0 Views
Last updated: 22 August 2026